2023

  1. ICD-10-CM Codes
    2. ›
  2. Z00-Z99
    3. ›
  3. Z19-Z19
    4. ›
  4. Z19-
    5. ›
  5. 2023 ICD-10-CM Diagnosis Code Z19.1

2023 ICD-10-CM Diagnosis Code Z19.1

New Call-to-action

Hormone sensitive malignancy status

    2017 - New Code 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • Z19.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM Z19.1 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of Z19.1 - other international versions of ICD-10 Z19.1 may differ.
The following code(s) above Z19.1 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to Z19.1:
  • Z00-Z99
    2023 ICD-10-CM Range Z00-Z99

    Factors influencing health status and contact with health services

    Note
    • Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
    • (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
    • (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
    Factors influencing health status and contact with health services
  • Z19
    ICD-10-CM Diagnosis Code Z19

    Hormone sensitivity malignancy status

      2017 - New Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Code First
    • malignant neoplasm - see Table of Neoplasms, by site, malignant
    Hormone sensitivity malignancy status
Present On Admission
POA Help
"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
  • Z19.1 is considered exempt from POA reporting.
ICD-10-CM Z19.1 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 951 Other factors influencing health status

Convert Z19.1 to ICD-9-CM

Code History
  • 2017 (effective 10/1/2016): New code
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to Z19.1:
  • Use Additional: C61
    ICD-10-CM Diagnosis Code C61

    Malignant neoplasm of prostate

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Male Dx
    Type 1 Excludes
    • malignant neoplasm of seminal vesicle (C63.7)
    Use Additional
    • code, if applicable, to identify:
    • hormone sensitivity status (Z19.1-Z19.2)
    • rising PSA following treatment for malignant neoplasm of prostate (R97.21)

Diagnosis Index entries containing back-references to Z19.1:

ICD-10-CM Codes Adjacent To Z19.1
Z18.31 Retained animal quills or spines
Z18.32 Retained tooth
Z18.33 Retained wood fragments
Z18.39 Other retained organic fragments
Z18.8 Other specified retained foreign body
Z18.81 Retained glass fragments
Z18.83 Retained stone or crystalline fragments
Z18.89 …… fragments
Z18.9 Retained foreign body fragments, unspecified material
Z19 Hormone sensitivity malignancy status
Z19.1 Hormone sensitive malignancy status
Z19.2 Hormone resistant malignancy status
Z20 Contact with and (suspected) exposure to communicable diseases
Z20.0 Contact with and (suspected) exposure to intestinal infectious diseases
Z20.01 …… due to Escherichia coli (E. coli)
Z20.09 Contact with and (suspected) exposure to other intestinal infectious diseases
Z20.1 Contact with and (suspected) exposure to tuberculosis
Z20.2 Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Z20.3 Contact with and (suspected) exposure to rabies
Z20.4 Contact with and (suspected) exposure to rubella
Z20.5 Contact with and (suspected) exposure to viral hepatitis

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © | ICD10data.com